Cushing's Disease in Dogs: Symptoms, Diagnosis & Treatment Guide
Complete guide to Cushing's disease in dogs: learn early symptoms, diagnostic tests, treatment options, costs, and life expectancy from veterinary sources.
If your dog seems thirstier than usual, is losing hair in patches, or has developed a pot-bellied appearance, you may be dealing with one of the most common endocrine disorders in middle-aged and older dogs. Cushing's disease (hyperadrenocorticism) affects an estimated 1 to 2 out of every 1,000 dogs annually in the United States, according to veterinary endocrinology data referenced by the Merck Veterinary Manual. It occurs when the body produces excessive cortisol — the "stress hormone" — over a prolonged period. Roughly 80–85% of cases originate from a benign pituitary tumor (pituitary-dependent hyperadrenocorticism, or PDH), while 15–20% stem from an adrenal gland tumor. A third form, iatrogenic Cushing's, results from long-term corticosteroid medication use. Understanding this disease is the first step toward getting your dog back to feeling like themselves.
What Is Cushing's Disease in Dogs?
Cushing's disease — named after neurosurgeon Harvey Cushing, who first described the human condition in 1932 — is a hormonal disorder where the adrenal glands (two small organs sitting atop the kidneys) chronically overproduce cortisol. In a healthy dog, the hypothalamus signals the pituitary gland to release adrenocorticotropic hormone (ACTH), which tells the adrenals to release cortisol. When cortisol levels are adequate, the feedback loop shuts off ACTH production. In Cushing's disease, this feedback loop breaks down.
There are three recognized forms:
- Pituitary-Dependent Hyperadrenocorticism (PDH): A benign microadenoma (rarely a macroadenoma) on the pituitary gland overproduces ACTH, constantly stimulating both adrenal glands. This accounts for approximately 80–85% of naturally occurring cases.
- Adrenal-Dependent Hyperadrenocorticism (ADH): A tumor on one adrenal gland autonomously secretes cortisol independent of ACTH signaling. Roughly half of adrenal tumors are malignant (adenocarcinomas), and half are benign (adenomas). This form represents 15–20% of cases.
- Iatrogenic Cushing's Syndrome: Prolonged administration of corticosteroid medications (prednisone, dexamethasone, methylprednisolone) for conditions like allergies, autoimmune disease, or arthritis suppresses the normal HPA axis and produces Cushingoid symptoms. This form is reversible with gradual dose tapering under veterinary supervision.
The disease most commonly strikes dogs between 7 and 12 years of age, though it can appear in dogs as young as 4. There is no strong sex predilection, though some studies note a slight female bias in adrenal-dependent cases.
Recognizing the Symptoms: Early Warnings vs. Advanced Signs
Cushing's disease is notoriously insidious. Symptoms develop gradually over months or even years, and many owners initially attribute changes to "just getting old." The following checklist organizes clinical signs by progression stage to help you identify when something warrants investigation.
| Category | Early Warning Signs | Advanced / Severe Symptoms |
|---|---|---|
| Appetite & Thirst | Increased thirst (polydipsia), increased appetite (polyphagia) | Excessive water consumption (>100 mL/kg/day), begging/food stealing, weight gain despite activity |
| Urination | More frequent urination (polyuria), asking to go out at night | House soiling in previously trained dogs, urinary accidents overnight, dilute/pale urine |
| Coat & Skin | Thinning coat, slower hair regrowth after grooming | Bilateral symmetrical hair loss (alopecia) on trunk/flanks, thin/fragile skin, dark hyperpigmented patches, recurrent skin infections, calcinosis cutis (calcium deposits in skin) |
| Body Shape | Mild abdominal rounding | Pronounced "pot-bellied" appearance, muscle wasting along spine and limbs, visible rib prominence with distended abdomen |
| Energy & Behavior | Slightly reduced stamina on walks, more sleeping | Significant lethargy, reluctance to jump or climb stairs, panting at rest, muscle weakness |
| Reproductive | Irregular heat cycles in intact females | Testicular atrophy in intact males, anestrus in intact females |
| Neurological (rare) | — | Disorientation, head pressing, seizures (associated with large pituitary macroadenomas >1 cm) |
A hallmark clinical picture — often called the "Cushingoid appearance" — combines the pot-bellied silhouette, symmetrical hair loss sparing the head and legs, and thin, almost translucent skin with visible surface blood vessels. Not every dog shows every symptom; the presentation varies based on disease duration and individual physiology.
Risk Factors: Which Dogs Are Most Vulnerable?
🔍 Risk Factor Summary
- Age: Peak onset 7–12 years; rare under age 4
- Breed: Poodles (especially Miniature and Standard), Dachshunds, Boston Terriers, Yorkshire Terriers, Beagles, Boxers, German Shepherds, and Terrier breeds show elevated prevalence
- Weight: No direct weight causation, but obese dogs may show overlapping symptoms that delay diagnosis
- Sex: Roughly equal in PDH; slight female predisposition in adrenal-dependent cases
- Medication history: Any dog on chronic corticosteroid therapy (oral, injectable, topical, or ophthalmic) is at risk for iatrogenic Cushing's
- Genetics: Familial clustering has been observed in some Poodle and Dachshund lines, though no single gene has been definitively identified
It is worth noting that small-breed dogs are disproportionately affected by PDH, while larger breeds — particularly German Shepherds — appear somewhat more likely to develop adrenal tumors. The American Kennel Club notes that breed awareness can help owners and veterinarians maintain a higher index of suspicion during routine wellness exams.
How Veterinarians Diagnose Cushing's Disease
Diagnosing Cushing's disease is one of the more complex workups in veterinary endocrinology. No single test provides a definitive answer in every case, so veterinarians use a staged approach — starting with screening tests and moving toward confirmatory and localization diagnostics.
Stage 1: Initial Screening Blood Work
Your veterinarian will begin with a complete blood count (CBC) and serum biochemistry panel. Common findings that raise suspicion include:
- Elevated alkaline phosphatase (ALP) — often the most prominent change, seen in 85–90% of cases
- Elevated ALT (alanine aminotransferase)
- Elevated blood glucose (hyperglycemia)
- Elevated cholesterol (hypercholesterolemia)
- Dilute urine (low urine specific gravity, typically <1.020)
- Neutrophilia, lymphopenia, and eosinopenia (the "stress leukogram" pattern)
Stage 2: Confirmatory Endocrine Testing
Three primary tests confirm or rule out Cushing's disease:
| Test | How It Works | Sensitivity | Estimated Cost |
|---|---|---|---|
| Low-Dose Dexamethasone Suppression Test (LDDST) | Injects a small dose of dexamethasone; blood cortisol is measured at 0, 4, and 8 hours. In healthy dogs, dexamethasone suppresses cortisol. In Cushingoid dogs, it does not. | 90–95% | $200–$400 |
| ACTH Stimulation Test | Measures cortisol before and 1–2 hours after synthetic ACTH injection. Exaggerated response suggests Cushing's. Also used to monitor treatment. | 80–85% (PDH); higher for ADH | $150–$350 |
| Urine Cortisol:Creatinine Ratio (UCCR) | A free-catch morning urine sample is analyzed. Elevated ratio suggests hypercortisolism. Excellent screening tool (high sensitivity, lower specificity). | ~95% (screening only) | $50–$100 |
Stage 3: Differentiating PDH from ADH
Once Cushing's is confirmed, your vet needs to determine which form is present, as treatment differs substantially:
- High-Dose Dexamethasone Suppression Test (HDDST): A higher dexamethasone dose can suppress cortisol in PDH dogs (because the pituitary tumor still partially responds to feedback) but not in ADH dogs (adrenal tumors are autonomous). Accuracy around 70–75%.
- Endogenous ACTH Concentration: Blood is drawn and sent to a specialized lab. High ACTH suggests PDH; low or undetectable ACTH suggests ADH. Cost: $100–$200 plus specialized shipping.
- Abdominal Ultrasound: Evaluates adrenal gland size and shape. Bilaterally enlarged adrenals suggest PDH; one enlarged with one atrophied adrenal suggests ADH. Also screens for adrenal tumor invasion into surrounding vasculature. Cost: $300–$600.
- CT or MRI of the Head: Recommended when neurological signs suggest a pituitary macroadenoma (>1 cm) or prior to radiation therapy. Cost: $1,000–$2,500 depending on facility.
Treatment Options: Medical, Surgical, and Supportive Care
Treatment choice depends heavily on whether your dog has PDH or ADH, the severity of symptoms, tumor size, and your budget. Here is a detailed comparison of the primary approaches.
| Treatment | Used For | Mechanism | Success Rate | Est. Annual Cost |
|---|---|---|---|---|
| Trilostane (Vetoryl®) | PDH and ADH (first-line medical therapy) | Inhibits 3β-hydroxysteroid dehydrogenase, blocking cortisol synthesis in the adrenal glands | 80–90% clinical improvement | $600–$1,800/yr (dose-dependent) |
| Mitotane (Lysodren®) | PDH (older therapy, still used) | Selectively destroys the cortisol-producing zona fasciculata and reticulosa of the adrenal cortex | 70–85% clinical improvement | $300–$800/yr |
| Adrenalectomy (surgical removal) | ADH (benign adrenal adenomas) | Complete removal of the affected adrenal gland; can be curative if tumor is benign and fully excised | Curative in ~70% of benign cases; perioperative mortality 5–10% | $3,000–$7,000 (one-time) |
| Hypophysectomy (pituitary surgery) | PDH (select cases, limited availability) | Transsphenoidal removal of the pituitary tumor. Available at a small number of specialty centers in the US. | Remission in 70–85% of microadenoma cases | $6,000–$12,000 (one-time) |
| Radiation Therapy | PDH with macroadenoma causing neurological signs | Stereotactic or conventional radiation shrinks pituitary mass; medical therapy still needed for cortisol control | Reduces tumor size in 70–80%; does not normalize cortisol alone | $4,000–$8,000 (one-time course) |
| Iatrogenic: Gradual Steroid Taper | Iatrogenic Cushing's only | Slowly reducing exogenous corticosteroid dose allows HPA axis recovery. Never stop steroids abruptly. | Fully reversible in most cases over 3–12 months | Minimal (monitoring visits only) |
Trilostane (Vetoryl®): The Current Gold Standard
Trilostane has become the first-line medical treatment for both PDH and ADH since receiving FDA approval for veterinary use. It is administered once or twice daily with food, and dosing is weight-based:
- Dogs 5–20 lb (2.3–9 kg): 30 mg once daily
- Dogs 20–40 lb (9–18 kg): 60 mg once daily
- Dogs 40–80 lb (18–36 kg): 120 mg once daily
- Dogs >80 lb (>36 kg): 120–240 mg, often split into twice-daily dosing
Your veterinarian will adjust the dose based on ACTH stimulation test results performed at 10–14 days, 30 days, 90 days, and then every 3–6 months. Some dogs require twice-daily dosing for adequate 24-hour cortisol control, which your vet will determine based on clinical response and pre-pill cortisol levels.
Monitoring and Dose Adjustments
Lifelong monitoring is non-negotiable with medical management. Over-suppression of cortisol can cause an Addisonian crisis (hypoadrenocorticism), a potentially fatal emergency characterized by vomiting, diarrhea, collapse, and electrolyte imbalances. Each monitoring visit typically includes an ACTH stimulation test ($150–$350) and basic blood work ($80–$150).
Prognosis and Life Expectancy by Disease Type
Most owners want to know: how long will my dog live with Cushing's disease? The answer depends on the form, the treatment approach, and whether complications develop.
| Disease Form | With Treatment | Without Treatment | Key Variables |
|---|---|---|---|
| PDH (microadenoma) | Median survival 2–2.5 years; many dogs live 3–5+ years with consistent monitoring | Median survival approximately 1 year; progressive decline in quality of life | Response to trilostane, owner compliance with monitoring, concurrent conditions |
| PDH (macroadenoma) | Variable: 6 months to 2+ years depending on neurological involvement and treatment (radiation + medical) | Poor: neurological deterioration over weeks to months | Tumor size, rate of growth, access to radiation therapy |
| ADH (benign adenoma) | Curative with successful adrenalectomy; 18+ months with medical management | Progressive: 12–18 months average | Surgical candidacy, tumor size and vascular invasion |
| ADH (malignant adenocarcinoma) | Guarded: 6–18 months even with surgery if metastasis present | Poor: 3–9 months | Degree of vascular invasion, metastatic spread at diagnosis |
| Iatrogenic | Full recovery expected with proper tapering; weeks to months | Not applicable — condition is medication-induced | Duration of prior steroid use, underlying condition requiring steroids |
It is important to set realistic expectations. Cushing's disease is generally a manageable chronic condition rather than a curable one (with the exception of some adrenal tumors and iatrogenic cases). Most dogs with PDH who are well-managed on trilostane maintain good quality of life — drinking and urinating normally, regaining their coat, and returning to normal activity levels within 2–4 months of starting treatment.
Home Care, Daily Management, and Lifestyle Adjustments
Managing a Cushingoid dog at home requires consistent routines and keen observation. Here is what your daily life will look like once your dog is stabilized:
Daily Care Essentials
- Medication timing: Administer trilostane with food at the same time(s) each day. Splitting the dose into morning and evening feedings often provides more stable 24-hour cortisol control.
- Water access: Never restrict water intake. Polydipsia will improve with treatment, but during the adjustment period, ensure unlimited fresh water access. Consider adding water stations in multiple rooms.
- Walk schedule: More frequent bathroom breaks during the initial treatment phase. Expect gradual normalization over 4–8 weeks.
- Appetite monitoring: Polyphagia should decrease as cortisol normalizes. Continue measuring food portions to prevent obesity — a common comorbidity.
- Skin care: Dogs with Cushing's have fragile, infection-prone skin. Bathe with gentle, veterinary-recommended shampoos (chlorhexidine-based if secondary pyoderma is present). Avoid close grooming clips until the coat recovers.
Warning Signs to Monitor at Home
Keep a simple log tracking your dog's daily water consumption (measured in cups or mL), appetite, energy level, and any vomiting or diarrhea episodes. Bring this log to every veterinary appointment — it provides invaluable data for dose adjustments.
- Sudden vomiting, diarrhea, or refusal to eat — possible Addisonian crisis from over-suppression
- Extreme lethargy, weakness, or collapse — electrolyte emergency
- Disorientation, circling, head pressing, or seizures — possible pituitary macroadenoma progression
- Rapidly worsening panting or difficulty breathing — could indicate pulmonary thromboembolism (a known complication of Cushing's)
- Complete loss of appetite lasting more than 24 hours while on trilostane — hold the next dose and contact your vet
For suspected poisoning or medication overdose, contact the ASPCA Animal Poison Control Center: (888) 426-4435 (24/7, consultation fee applies) or the Pet Poison Helpline: (855) 764-7661.
Nutrition Considerations
There is no specific "Cushing's diet," but certain nutritional principles support management:
- Moderate fat: Cushingoid dogs are prone to hyperlipidemia (elevated blood fats). Choose a diet with moderate fat content (12–15% on a dry matter basis for most dogs).
- High-quality protein: Muscle wasting is a hallmark of the disease. Adequate protein (25–30% DM) supports lean mass retention.
- Controlled sodium: Some Cushingoid dogs develop hypertension. Avoid high-sodium treats and table scraps.
- Joint support: Muscle weakness places additional stress on joints. Consider omega-3 fatty acid supplementation (EPA/DHA at 30–50 mg/kg combined daily) after discussing with your vet.
Look for an AAFCO statement of nutritional adequacy on any commercial diet. If you prepare homemade meals, consult a board-certified veterinary nutritionist to ensure completeness.
The Real Cost of Managing Cushing's Disease
Budgeting for Cushing's disease is one of the most common concerns owners raise. Costs vary significantly by region, dog size (which determines medication dose), and whether complications arise. Here is a realistic breakdown based on typical US veterinary pricing in 2025–2026:
| Expense Category | Low Estimate | Typical Range | High Estimate |
|---|---|---|---|
| Initial diagnostic workup (blood work + LDDST/ACTH stim + ultrasound) | $500 | $800–$1,500 | $2,500+ (with advanced imaging) |
| Annual medication (trilostane, weight-dependent) | $400 (small dog) | $800–$1,500 | $2,000+ (large dog, twice-daily dosing) |
| Annual monitoring visits (ACTH stim + blood work, 2–4 per year) | $400 | $600–$1,200 | $1,800+ |
| Emergency treatment (Addisonian crisis hospitalization) | $800 | $1,500–$3,000 | $5,000+ |
| Adrenalectomy (if applicable, one-time) | $3,000 | $4,000–$6,000 | $8,000+ |
| Estimated First-Year Total (medical management) | $1,800 | $2,500–$4,500 | $6,000+ |
| Estimated Ongoing Annual Cost (years 2+) | $1,000 | $1,500–$3,000 | $4,000+ |
Pet insurance can significantly offset these costs if the condition is not pre-existing. Most comprehensive accident-and-illness plans cover diagnostic testing, medication, and monitoring for conditions that arise after the policy effective date. Average monthly premiums for a middle-aged dog range from $35–$80 depending on breed, location, and deductible structure.
Can Cushing's Disease Be Prevented?
Because the vast majority of Cushing's disease cases arise from spontaneous pituitary or adrenal tumors, there is no reliable prevention for the naturally occurring forms (PDH and ADH). However, there are steps you can take to reduce risk and catch the disease early:
- Minimize unnecessary corticosteroid use: Discuss alternatives with your vet for chronic conditions. For allergies, options like oclacitinib (Apoquel®), lokivetmab (Cytopoint®), or allergen-specific immunotherapy may reduce the need for long-term prednisone.
- Annual senior blood work: For dogs over age 7, annual wellness panels can catch early ALP elevations or urine concentration changes before obvious symptoms develop.
- Monitor medication side effects: If your dog requires corticosteroids for any condition, watch for early Cushingoid signs and report them promptly. Your vet may adjust the dose or transition to an alternative therapy.
- Breed awareness: If you own a predisposed breed (Poodle, Dachshund, Boston Terrier, Yorkshire Terrier), mention Cushing's awareness during wellness visits so your vet maintains a higher index of suspicion.
Frequently Asked Questions
What is the life expectancy of a dog with Cushing's disease?
With proper treatment and monitoring, most dogs with pituitary-dependent Cushing's disease live 2–5 years after diagnosis, with many exceeding the median. Dogs with benign adrenal tumors that are surgically removed may be fully cured and live a normal lifespan. Without treatment, survival averages approximately one year with declining quality of life. These figures are medians — individual outcomes vary based on age, comorbidities, treatment response, and tumor characteristics.
Can Cushing's disease in dogs be cured?
In most cases (PDH), Cushing's disease is managed rather than cured — it requires lifelong medication and monitoring. However, some adrenal tumors (benign adenomas) can be surgically removed with curative intent. Iatrogenic Cushing's is fully reversible by tapering the causative medication. Pituitary hypophysectomy, available at a limited number of specialty centers, offers potential long-term remission for PDH but is not widely accessible.
Which dog breeds are most prone to Cushing's disease?
Breeds with recognized higher prevalence include Poodles (all sizes), Dachshunds, Boston Terriers, Yorkshire Terriers, Beagles, Boxers, and various Terrier breeds. Small-breed dogs in general are overrepresented for pituitary-dependent forms. German Shepherds and larger breeds show a somewhat higher relative risk for adrenal tumors. However, Cushing's can affect any breed.
How much does Cushing's disease treatment cost per month?
Monthly costs typically range from $75–$250 for medication (trilostane) depending on your dog's size and dose, plus $50–$150 per month when averaged across annual monitoring visits. In total, budget approximately $150–$400 per month for ongoing management. Emergency complications, dose adjustments, or concurrent conditions will increase this figure.
Is Cushing's disease painful for dogs?
Cushing's disease itself is not typically painful in the way that arthritis or dental disease is. However, untreated dogs experience significant discomfort from muscle weakness, skin infections, abdominal distension, and the constant drive to eat and drink. Secondary complications like urinary tract infections, calcinosis cutis (hard calcium plaques in the skin), and pancreatitis can cause pain. Proper treatment dramatically improves comfort and quality of life.
What happens if I don't treat my dog's Cushing's disease?
Without treatment, Cushing's disease progressively worsens. Chronic cortisol excess suppresses the immune system (leading to recurrent infections), causes severe muscle wasting, elevates blood pressure, increases the risk of diabetes mellitus, and predisposes dogs to blood clots (pulmonary thromboembolism). Quality of life declines steadily, and most untreated dogs survive approximately one year. If treatment is financially prohibitive, discuss palliative care options and quality-of-life assessments with your veterinarian.
Can I give my dog natural supplements instead of medication for Cushing's?
There is no peer-reviewed evidence that any supplement, herbal remedy, or natural product can effectively treat Cushing's disease in dogs. Some supplements marketed for "adrenal support" (such as melatonin, lignans from flaxseed, or ashwagandha) have been studied in limited contexts — melatonin may modestly help with hair regrowth, and lignans showed some cortisol-lowering effect in a small University of Tennessee study — but none replace trilostane or mitotane for controlling the disease. Always consult your veterinarian before adding supplements, as some can interact with prescribed medications.
Sources consulted: Merck Veterinary Manual — Hyperadrenocorticism in Dogs, American Kennel Club — Cushing's Disease in Dogs, and peer-reviewed literature from the Journal of Veterinary Internal Medicine.
Dr. Hannah Wickes
All our authors care for dogs every day — read more of their work on the authors page.



